Thus, we conclude that NF-kB p65 Ser536 plays a significant role in regulating CCL2 expression and the T/E fusion, NF-kB p536 and CCL2 may form a signal pathway that promotes tumor progression. This evidence concerns the gene NFKB1 and neoplasm.